MDxHealth Oppenheimer, BTIG Initiate Coverage of MDxHealth at Outperform, Buy Oppenheimer set an $18 price target for the company's shares, and BTIG set a $15 price target. In Brief This Week: Caris Life Sciences, Psomagen, Tempus, CareDx, HTG Molecular, Epigenomics, More News items for the week of Nov 8, 2021. MDxHealth Prices IPO of American Depositary Shares The diagnostics company is offering 3.75 million ADSs at $12 per share and is hoping to raise gross proceeds of $45 million. MDxHealth Q3 Revenues Grow 23 Percent The firm's services revenues for Q3 rose 23 percent, and test volume for its ConfirmMDx assay rose 5 percent, but volume for its SelectMDx test fell 1 percent. MDxHealth Files for IPO of American Depositary Shares The company, which confidentially submitted a draft registration statement to the SEC in September, has now publicly filed for listing on the Nasdaq. Sep 1, 2021 MDxHealth Files for IPO of American Depository Shares Aug 26, 2021 MDxHealth H1 2021 Revenues Up 9 Percent As Testing Volumes Rebound May 21, 2021 Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests Mar 3, 2021 MDxHealth 2020 Revenues Up 57 Percent Mar 2, 2021 Oppenheimer Initiates Coverage of MDxHealth at Outperform Oct 21, 2020 MDxHealth Q3 2020 Revenues Drop 6 Percent Aug 26, 2020 MDxHealth H1 2020 Revenues Down 9 Percent on Declining Test Volumes Apr 27, 2020 MDxHealth Receives €12.7M Investment From MVM Partners Apr 9, 2020 MDxHealth Q1 Revenues Up 24 Percent; Company Suspends 2020 Guidance Feb 26, 2020 MDxHealth 2019 Revenues Fall 58 Percent Nov 11, 2019 MDxHealth Revenues Down 35 Percent for Nine-Month 2019 Period Oct 4, 2019 Local Coverage Determinations Roundup: Myriad, AltheaDx, Castle Bio, Razor Genomics, and More Sep 26, 2019 MDxHealth Plans Private Placement, Signs $9.9M Loan Agreement Aug 29, 2019 MDxHealth H1 2019 Revenues Fall 37 Percent Aug 22, 2019 Local Coverage Determinations Roundup: MDxHealth, Myriad, AltheaDx, Natera, and More Apr 24, 2019 MDxHealth Q1 Revenues Drop 51 Percent Feb 28, 2019 MDxHealth Posts Flat Year-Over-Year Revenues for 2018 Feb 14, 2019 MDxHealth, LifeLabs Ink Distribution Agreement for Prostate Cancer Assay Jan 14, 2019 MDxHealth Preliminary 2018 Revenues Drop Nearly 1 Percent Nov 26, 2018 MDxHealth Prostate Cancer Test Gains New York State Approval Load More Breaking News Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution Thermo Fisher, Oncocyte Ink Development, Comarketing Deal for Cancer IVDs The Scan And a Fourth? A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times. For Better Science Software A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports. Recommendation Explanations The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information. Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.